Cargando…

Association between Five Common Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms and Colorectal Cancer Susceptibility

The plasminogen activator inhibitor-1 (PAI-1) is expressed in many cancer cell types and modulates cancer growth, invasion, and angiogenesis. The present study investigated the association between five PAI-1 gene polymorphisms and colorectal cancer (CRC) risk. Five PAI-1 polymorphisms (−844G > A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Jisu, An, Hui Jeong, Kim, Jung Oh, Jun, Hak Hoon, Kim, Woo Ram, Kim, Eo Jin, Oh, Doyeun, Kim, Jong Woo, Kim, Nam Keun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352892/ https://www.ncbi.nlm.nih.gov/pubmed/32570732 http://dx.doi.org/10.3390/ijms21124334

Ejemplares similares

Association of Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms with Osteoporotic Vertebral Compression Fractures (OVCFs) in Postmenopausal Women
por: Kim, Jung Oh, et al.
Publicado: (2016)

Association of Polymorphisms in Plasminogen Activator Inhibitor-1 (PAI-1), Tissue Plasminogen Activator (tPA), and Renin (REN) with Recurrent Pregnancy Loss in Korean Women
por: Cho, Hee Young, et al.
Publicado: (2021)

Genetic Variants of HOTAIR Associated With Colorectal Cancer Susceptibility and Mortality
por: Kim, Jung Oh, et al.
Publicado: (2020)

Analysis of the Association Between MicroRNA Biogenesis Gene Polymorphisms and Venous Thromboembolism in Koreans
por: Ko, Eun Ju, et al.
Publicado: (2019)

3’-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population
por: Cho, Sung Hwan, et al.
Publicado: (2015)

The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population
por: Park, Han Sung, et al.
Publicado: (2020)

Genetic associations between the miRNA polymorphisms miR-130b (rs373001), miR-200b (rs7549819), and miR-495 (rs2281611) and colorectal cancer susceptibility
por: Kim, Eun-Gyo, et al.
Publicado: (2019)

Interplay between 3′-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans
por: Jeon, Young Joo, et al.
Publicado: (2014)

Association of MicroRNA Biogenesis Genes Polymorphisms with Ischemic Stroke Susceptibility and Post-Stroke Mortality
por: Kim, Jung Oh, et al.
Publicado: (2018)

Genetic variants in 3′-UTRs of methylenetetrahydrofolate reductase (MTHFR) predict colorectal cancer susceptibility in Koreans
por: Joo Jeon, Young, et al.
Publicado: (2015)

Association between PAI-1 Polymorphisms and Ischemic Stroke in a South Korean Case-Control Cohort
por: Choi, Gun Ho, et al.
Publicado: (2023)

PAI-1, the Plasminogen System, and Skeletal Muscle
por: Rahman, Fasih Ahmad, et al.
Publicado: (2020)

Prognostic utility of ADAMTS13 activity for the atypical hemolytic uremic syndrome (aHUS) and comparison of complement serology between aHUS and thrombotic thrombocytopenic purpura
por: Oh, Jisu, et al.
Publicado: (2019)

Plasminogen Activator Inhibitor Type 1 (PAI-1) A15T Gene Polymorphism Is Associated with Prognosis in Patients with EGFR Mutation Positive Pulmonary Adenocarcinoma
por: Lim, Ju Eun, et al.
Publicado: (2013)

Plasminogen activator inhibitor-1 (PAI-1) expression in endometriosis
por: Alotaibi, Fahad T., et al.
Publicado: (2019)

3′-UTR Polymorphisms of MTHFR and TS Associated with Osteoporotic Vertebral Compression Fracture Susceptibility in Postmenopausal Women
por: Ahn, Tae-Keun, et al.
Publicado: (2018)

Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head
por: Kim, Hye- Ok, et al.
Publicado: (2011)

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.
por: Bouchet, C., et al.
Publicado: (1994)

Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women
por: Ozgen, Merih, et al.
Publicado: (2012)

Role of 4G/5G plasminogen activator inhibitor-1 (PAI-1) gene polymorphism and the PAI-1 plasma levels in the outcome of patients with severe sepsis
por: Lorente, L, et al.
Publicado: (2009)

MPG and NPRL3 Polymorphisms Are Associated with Ischemic Stroke Susceptibility and Post-Stroke Mortality
por: Ryu, Chang Soo, et al.
Publicado: (2020)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
por: Yousef, Aly A, et al.
Publicado: (2020)

Frequency of Pro475Ser Polymorphism of ADAMTS13 Gene and Its Association with ADAMTS-13 Activity in the Korean Population
por: Jang, Mun Ju, et al.
Publicado: (2008)

Genetics of Plasminogen Activator Inhibitor-1 (PAI-1) in a Ghanaian Population
por: White, Marquitta J., et al.
Publicado: (2015)

Increased expression of urokinase type plasminogen activator(u-PA), plasminogen activator inhibitor-1(PAI-1), and collagenases in Caco-2 cells infected by Salmonella typhimurium.
por: Park, C. G., et al.
Publicado: (1997)

Asymptomatic pneumatosis intestinalis following chemotherapy for B lymphoblastic leukemia with recurrent genetic abnormalities in an adolescent patient
por: Shin, Dae-Kyu, et al.
Publicado: (2012)

Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
Publicado: (2021)

Association of the Single Nucleotide Polymorphisms in microRNAs 130b, 200b, and 495 with Ischemic Stroke Susceptibility and Post-Stroke Mortality
por: Kim, Jinkwon, et al.
Publicado: (2016)

Association study of AGO1 and AGO2 genes polymorphisms with recurrent pregnancy loss
por: Kim, Young Ran, et al.
Publicado: (2019)

Genetic variants of MUC4 are associated with susceptibility to and mortality of colorectal cancer and exhibit synergistic effects with LDL-C levels
por: Kwon, Min Jung, et al.
Publicado: (2023)

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Levels in Patients with Acute Paraquat Intoxication
por: Seok, Su-Jin, et al.
Publicado: (2011)

Association of Methylenetetrahydrofolate Reductase (MTHFR 677C>T and 1298A>C) Polymorphisms and Haplotypes with Silent Brain Infarction and Homocysteine Levels in a Korean Population
por: Han, In Bo, et al.
Publicado: (2010)

Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
por: Party, Hélène, et al.
Publicado: (2019)

3′-UTR Polymorphisms in the Vascular Endothelial Growth Factor Gene (VEGF) Contribute to Susceptibility to Recurrent Pregnancy Loss (RPL)
por: An, Hui Jeong, et al.
Publicado: (2019)

Association between HOTAIR lncRNA Polymorphisms and Coronary Artery Disease Susceptibility
por: Kim, In-Jai, et al.
Publicado: (2021)

Gender-specific Association between Polymorphism of Vascular Endothelial Growth Factor (VEGF 936C > T) Gene and Patients with Stomach Cancer
por: Bae, Su Jin, et al.
Publicado: (2008)

Plasminogen Activator Inhibitor-1 (PAI-1) Gene Polymorphisms Associated with Cardiovascular Risk Factors Involved in Cerebral Venous Sinus Thrombosis
por: Gogu, Anca Elena, et al.
Publicado: (2021)

Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer.
por: Pierga, J. Y., et al.
Publicado: (1997)

Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
por: Ikeda, T, et al.
Publicado: (2002)

Criteria and Search for Specific Assays for Active Plasminogen Activator Inhibitor 1 (PAI-1) in Plasma
por: Kluft, C.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_hgr1nm024og4qdpto58gn7v586